BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Durante M, Formenti SC. Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway. Front Oncol 2018;8:192. [PMID: 29911071 DOI: 10.3389/fonc.2018.00192] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Vashi N, Bakhoum SF. The Evolution of STING Signaling and Its Involvement in Cancer. Trends Biochem Sci 2021;46:446-60. [PMID: 33461879 DOI: 10.1016/j.tibs.2020.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Durante M, Formenti S. Harnessing radiation to improve immunotherapy: better with particles? Br J Radiol 2020;93:20190224. [PMID: 31317768 DOI: 10.1259/bjr.20190224] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
3 Vesci L, Carollo V, Rosi A, De Santis R. Therapeutic efficacy of intra-tumor AvidinOX and low systemic dose biotinylated cetuximab, with and without cisplatin, in an orthotopic model of head and neck cancer. Oncol Lett 2019;17:3529-36. [PMID: 30867794 DOI: 10.3892/ol.2019.10003] [Reference Citation Analysis]
4 Keam S, Gill S, Ebert MA, Nowak AK, Cook AM. Enhancing the efficacy of immunotherapy using radiotherapy. Clin Transl Immunology 2020;9:e1169. [PMID: 32994997 DOI: 10.1002/cti2.1169] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
5 Adcock CS, Puneky LV, Campbell GS. Favorable Response of Metastatic Hepatocellular Carcinoma to Treatment with Trans-arterial Radioembolization Followed by Sorafenib and Nivolumab. Cureus. 2019;11:e4083. [PMID: 31019861 DOI: 10.7759/cureus.4083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
6 Philipp J, Le Gleut R, Toerne CV, Subedi P, Azimzadeh O, Atkinson MJ, Tapio S. Radiation Response of Human Cardiac Endothelial Cells Reveals a Central Role of the cGAS-STING Pathway in the Development of Inflammation. Proteomes 2020;8:30. [PMID: 33114474 DOI: 10.3390/proteomes8040030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Friedrich T, Henthorn N, Durante M. Modeling Radioimmune Response-Current Status and Perspectives. Front Oncol 2021;11:647272. [PMID: 33796470 DOI: 10.3389/fonc.2021.647272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Rech L, Rainer PP. The Innate Immune cGAS-STING-Pathway in Cardiovascular Diseases - A Mini Review. Front Cardiovasc Med 2021;8:715903. [PMID: 34381828 DOI: 10.3389/fcvm.2021.715903] [Reference Citation Analysis]
9 Goodhead DT. Neutrons are forever! Historical perspectives. Int J Radiat Biol 2019;95:957-84. [PMID: 30668204 DOI: 10.1080/09553002.2019.1569782] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
10 Jagetia GC, Jacob PS. (E)4-[4-N,N-dimethylaminophenyl]but-3-en-2-one mitigates radiation-induced chromosome damage in BALB/c mouse bone marrow. Mutat Res Genet Toxicol Environ Mutagen 2020;858-860:503238. [PMID: 33198928 DOI: 10.1016/j.mrgentox.2020.503238] [Reference Citation Analysis]
11 Mladenova V, Mladenov E, Scholz M, Stuschke M, Iliakis G. Strong Shift to ATR-Dependent Regulation of the G2-Checkpoint after Exposure to High-LET Radiation. Life (Basel) 2021;11:560. [PMID: 34198619 DOI: 10.3390/life11060560] [Reference Citation Analysis]
12 Bhartiya A, Batey D, Cipiccia S, Shi X, Rau C, Botchway S, Yusuf M, Robinson IK. X-ray Ptychography Imaging of Human Chromosomes After Low-dose Irradiation. Chromosome Res 2021;29:107-26. [PMID: 33786705 DOI: 10.1007/s10577-021-09660-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Bryll A, Krzyściak W, Jurczak A, Chrzan R, Lizoń A, Urbanik A. Changes in the Selected Antioxidant Defense Parameters in the Blood of Patients after High Resolution Computed Tomography. Int J Environ Res Public Health 2019;16:E1476. [PMID: 31027322 DOI: 10.3390/ijerph16091476] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Clay DE, Bretscher HS, Jezuit EA, Bush KB, Fox DT. Persistent DNA damage signaling and DNA polymerase theta promote broken chromosome segregation. J Cell Biol 2021;220:e202106116. [PMID: 34613334 DOI: 10.1083/jcb.202106116] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Mirjolet C, Nicol A, Limagne E, Mura C, Richard C, Morgand V, Rousseau M, Boidot R, Ghiringhelli F, Noel G, Burckel H. Impact of proton therapy on antitumor immune response. Sci Rep 2021;11:13444. [PMID: 34188135 DOI: 10.1038/s41598-021-92942-1] [Reference Citation Analysis]
16 Jiang X, Li Y, Zhang N, Gao Y, Han L, Li S, Li J, Liu X, Gong Y, Xie C. RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma. Cell Biosci 2021;11:74. [PMID: 33858512 DOI: 10.1186/s13578-021-00586-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Spaas M, Lievens Y. Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach? Front Med (Lausanne). 2019;6:244. [PMID: 31788476 DOI: 10.3389/fmed.2019.00244] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
18 Constanzo J, Faget J, Ursino C, Badie C, Pouget JP. Radiation-Induced Immunity and Toxicities: The Versatility of the cGAS-STING Pathway. Front Immunol 2021;12:680503. [PMID: 34079557 DOI: 10.3389/fimmu.2021.680503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Pu F, Chen F, Liu J, Zhang Z, Shao Z. Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application. Onco Targets Ther 2021;14:1501-16. [PMID: 33688199 DOI: 10.2147/OTT.S298958] [Reference Citation Analysis]
20 Hacker BC, Rafat M. Organoids as Complex In Vitro Models for Studying Radiation-Induced Cell Recruitment. Cell Mol Bioeng 2020;13:341-57. [PMID: 32952734 DOI: 10.1007/s12195-020-00625-0] [Reference Citation Analysis]
21 Dar TB, Henson RM, Shiao SL. Targeting Innate Immunity to Enhance the Efficacy of Radiation Therapy. Front Immunol 2018;9:3077. [PMID: 30692991 DOI: 10.3389/fimmu.2018.03077] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
22 Karamouzis MV, Papavassiliou AG. Combination of checkpoint inhibitors with other agents as a strategy to improve anti-cancer effect - a glimpse to the future. Expert Opin Investig Drugs 2018;27:569-72. [PMID: 29958097 DOI: 10.1080/13543784.2018.1494724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
23 Xue A, Shang Y, Jiao P, Zhang S, Zhu C, He X, Feng G, Fan S. Increased activation of cGAS‐STING pathway enhances radiosensitivity of non‐small cell lung cancer cells. Thoracic Cancer. [DOI: 10.1111/1759-7714.14400] [Reference Citation Analysis]
24 Meenakshi C, Venkatraman B. Correlation between cytogenetic biomarkers obtained from DC and CBMN assays caused by low dose radon exposure in smokers. International Journal of Radiation Biology 2019;95:1268-75. [DOI: 10.1080/09553002.2019.1625494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Jayakumar D, Kasturi KK. Micronucleus and Its Significance in Effusion Fluids. J Cytol 2020;37:58-61. [PMID: 31942100 DOI: 10.4103/JOC.JOC_42_19] [Reference Citation Analysis]
26 Zhu H, McNamara AL, McMahon SJ, Ramos-Mendez J, Henthorn NT, Faddegon B, Held KD, Perl J, Li J, Paganetti H, Schuemann J. Cellular Response to Proton Irradiation: A Simulation Study with TOPAS-nBio. Radiat Res 2020;194:9-21. [PMID: 32401689 DOI: 10.1667/RR15531.1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
27 Patel RR, Verma V, Barsoumian HB, Ning MS, Chun SG, Tang C, Chang JY, Lee PP, Gandhi S, Balter P, Dunn JD, Chen D, Puebla-Osorio N, Cortez MA, Welsh JW. Use of Multi-Site Radiation Therapy for Systemic Disease Control. Int J Radiat Oncol Biol Phys 2021;109:352-64. [PMID: 32798606 DOI: 10.1016/j.ijrobp.2020.08.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
28 Alsbeih G, Al-Harbi N, Ismail S, Story M. Impaired DNA Repair Fidelity in a Breast Cancer Patient With Adverse Reactions to Radiotherapy. Front Public Health 2021;9:647563. [PMID: 34164366 DOI: 10.3389/fpubh.2021.647563] [Reference Citation Analysis]
29 McGee HM, Marciscano AE, Campbell AM, Monjazeb AM, Kaech SM, Teijaro JR. Parallels Between the Antiviral State and the Irradiated State. J Natl Cancer Inst 2021;113:969-79. [PMID: 33252657 DOI: 10.1093/jnci/djaa190] [Reference Citation Analysis]
30 Yoo GS, Ahn WG, Kim SY, Kang W, Choi C, Park HC. Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study. Clin Mol Hepatol 2021;27:144-56. [PMID: 33280350 DOI: 10.3350/cmh.2020.0095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Babayan N, Grigoryan B, Khondkaryan L, Tadevosyan G, Sarkisyan N, Grigoryan R, Apresyan L, Aroutiounian R, Vorobyeva N, Pustovalova M, Grekhova A, Osipov AN. Laser-Driven Ultrashort Pulsed Electron Beam Radiation at Doses of 0.5 and 1.0 Gy Induces Apoptosis in Human Fibroblasts. Int J Mol Sci 2019;20:E5140. [PMID: 31627284 DOI: 10.3390/ijms20205140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
32 Herate C, Sabatier L. Retrospective biodosimetry techniques: Focus on cytogenetics assays for individuals exposed to ionizing radiation. Mutat Res Rev Mutat Res 2020;783:108287. [PMID: 32192645 DOI: 10.1016/j.mrrev.2019.108287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Goedegebuure RSA, de Klerk LK, Bass AJ, Derks S, Thijssen VLJL. Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer? Front Immunol 2018;9:3107. [PMID: 30692993 DOI: 10.3389/fimmu.2018.03107] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
34 Little MP, Wakeford R, Hatch M, Ainsbury EA, Tawn EJ. Chromosome Aberrations in a Group of People Exposed to Radioactive Releases from the Three Mile Island Nuclear Accident and Inferences for Radiation Effects. Radiat Res 2021;195:584-9. [PMID: 33788925 DOI: 10.1667/RADE-21-00046.1] [Reference Citation Analysis]
35 Plavc G, Jesenko T, Oražem M, Strojan P. Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer. Cancers (Basel) 2020;12:E3197. [PMID: 33143094 DOI: 10.3390/cancers12113197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Osrodek M, Wozniak M. Targeting Genome Stability in Melanoma-A New Approach to an Old Field. Int J Mol Sci 2021;22:3485. [PMID: 33800547 DOI: 10.3390/ijms22073485] [Reference Citation Analysis]
37 Tubin S, Yan W, Mourad WF, Fossati P, Khan MK. The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches. Future Oncol 2020;16:1137-51. [PMID: 32338046 DOI: 10.2217/fon-2020-0063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
38 Habibi M, Karyofyllis PK, Nikolakopoulou A, Papagiannis P, Karaiskos P, Georgakilas AG, Hatzi VI, Malakos I, Kollaros N, Mastorakou I, Voudris V, Terzoudi GI. The Use of Genotoxicity Endpoints as Biomarkers of Low Dose Radiation Exposure in Interventional Cardiology. Front Public Health 2021;9:701878. [PMID: 34368064 DOI: 10.3389/fpubh.2021.701878] [Reference Citation Analysis]
39 Liu K, Lan Y, Li X, Li M, Cui L, Luo H, Luo L. Development of small molecule inhibitors/agonists targeting STING for disease. Biomed Pharmacother 2020;132:110945. [PMID: 33254439 DOI: 10.1016/j.biopha.2020.110945] [Reference Citation Analysis]
40 Taïbi K, Abderrahim LA, Ferhat K, Betta S, Taïbi F, Bouraada F, Boussaid M. Ethnopharmacological study of natural products used for traditional cancer therapy in Algeria. Saudi Pharm J 2020;28:1451-65. [PMID: 33250653 DOI: 10.1016/j.jsps.2020.09.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Parsels LA, Zhang Q, Karnak D, Parsels JD, Lam K, Willers H, Green MD, Rehemtulla A, Lawrence TS, Morgan MA. Translation of DNA Damage Response Inhibitors as Chemoradiation Sensitizers From the Laboratory to the Clinic. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)02621-3. [PMID: 34348175 DOI: 10.1016/j.ijrobp.2021.07.1708] [Reference Citation Analysis]
42 Cheng S, Cheadle EJ, Illidge TM. Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response. Cancers (Basel) 2020;12:E2835. [PMID: 33008040 DOI: 10.3390/cancers12102835] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Žukauskaitė G, Domarkienė I, Matulevičienė A, Vaitėnienė EM, Arasimavičius J, Smailytė G, Kučinskas V, Ambrozaitytė L. Possible Protective Effect of LOXL1 Variant in the Cohort of Chernobyl Catastrophe Clean-Up Workers. Genes (Basel) 2021;12:1231. [PMID: 34440405 DOI: 10.3390/genes12081231] [Reference Citation Analysis]
44 Helm A, Fournier C, Durante M. Particle radiotherapy and molecular therapies: mechanisms and strategies towards clinical applications. Expert Rev Mol Med 2022;24:e8. [PMID: 35101155 DOI: 10.1017/erm.2022.2] [Reference Citation Analysis]
45 Helm A, Ebner DK, Tinganelli W, Simoniello P, Bisio A, Marchesano V, Durante M, Yamada S, Shimokawa T. Combining Heavy-Ion Therapy with Immunotherapy: An Update on Recent Developments. Int J Part Ther 2018;5:84-93. [PMID: 31773022 DOI: 10.14338/IJPT-18-00024.1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
46 Tinganelli W, Durante M. Carbon Ion Radiobiology. Cancers (Basel) 2020;12:E3022. [PMID: 33080914 DOI: 10.3390/cancers12103022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
47 Warmenhoven JW, Henthorn NT, Ingram SP, Chadwick AL, Sotiropoulos M, Korabel N, Fedotov S, Mackay RI, Kirkby KJ, Merchant MJ. Insights into the non-homologous end joining pathway and double strand break end mobility provided by mechanistic in silico modelling. DNA Repair 2020;85:102743. [DOI: 10.1016/j.dnarep.2019.102743] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
48 Candas-Green D, Xie B, Huang J, Fan M, Wang A, Menaa C, Zhang Y, Zhang L, Jing D, Azghadi S, Zhou W, Liu L, Jiang N, Li T, Gao T, Sweeney C, Shen R, Lin TY, Pan CX, Ozpiskin OM, Woloschak G, Grdina DJ, Vaughan AT, Wang JM, Xia S, Monjazeb AM, Murphy WJ, Sun LQ, Chen HW, Lam KS, Weichselbaum RR, Li JJ. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nat Commun 2020;11:4591. [PMID: 32929084 DOI: 10.1038/s41467-020-18245-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
49 Hou Y, Liang HL, Yu X, Liu Z, Cao X, Rao E, Huang X, Wang L, Li L, Bugno J, Fu Y, Chmura SJ, Wu W, Luo SZ, Zheng W, Arina A, Jutzy J, McCall AR, Vokes EE, Pitroda SP, Fu YX, Weichselbaum RR. Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity. Sci Transl Med 2021;13:eabb0130. [PMID: 33627484 DOI: 10.1126/scitranslmed.abb0130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Plavc G, Strojan P. Combining radiotherapy and immunotherapy in definitive treatment of head and neck squamous cell carcinoma: review of current clinical trials. Radiol Oncol 2020;54:377-93. [PMID: 33064670 DOI: 10.2478/raon-2020-0060] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
51 Farkas G, Kocsis ZS, Székely G, Mihály D, Pesznyák C, Pócza T, Major T, Polgár C, Jurányi Z. Quantifying biological effects of radiation from high-energy linear accelerators on lymphocytes. J Radiat Res 2020;61:73-81. [PMID: 31825080 DOI: 10.1093/jrr/rrz073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]